Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 58 (3) , 183-186
- https://doi.org/10.1080/00365519850186562
Abstract
(1998). Neuron-specific enolase concentrations in serum and cerebrospinal fluid in patients with no previous history of neurological disorder. Scandinavian Journal of Clinical and Laboratory Investigation: Vol. 58, No. 3, pp. 183-186.Keywords
This publication has 17 references indexed in Scilit:
- Serum neuron‐specific enolase in human status epilepticusNeurology, 1995
- Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinomaJournal of Neuro-Oncology, 1994
- Neuron-specific enolase in cerebrospinal fluid of patients with metastatic and non-metastatic neurological diseaseEuropean Journal Of Cancer, 1993
- High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles.Clinical Chemistry, 1989
- Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluidClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Age-dependent differences of distribution and clearance patterns in normal RIHSA cisternogramsNeuroradiology, 1976